Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

Summary Immunotherapy of chronic viral diseases with vaccines is an important but unproven concept. We investigated the effect of a vaccine containing recombinant glycoprotein D (gD2) of herpes simplex virus type 2 (HSV-2) on the frequency of symptomatic outbreaks in patients with genital herpes. 98...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1994-06, Vol.343 (8911), p.1460-1463
Hauptverfasser:	Straus, S.E, Savarese, B, Krause, P.R, Kost, R.G, Meier, J.L, Corey, L, Barnum, G, Burke, R.L, Sekulovich, R, Adair, S.F, Dekker, C.L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Viral - analysis Biological and medical sciences Double-Blind Method Female Herpes Genitalis - therapy Herpes viruses Herpesvirus 2, Human - immunology Human viral diseases Humans Immunity (Disease) Immunotherapy Infectious diseases Male Medical research Medical sciences Middle Aged Outbreaks Recombinant Proteins Recurrence Treatment Outcome Vaccines Viral diseases Viral diseases of the genital and urinary system Viral Envelope Proteins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!